Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmadata Oy
OY
Active
Y-tunnus 0761186-7
Mechelininkatu 1A, 00180
Helsinki
Computer programming activities
·
NACE 6210
Est. 1989 · 37 years old
38 employees
www.pharmadata.fi
Share
Finland
/
Companies
/
Computer programming activities
/
Pharmadata Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
11M
8M
6M
3M
0M
2021: 7M
7M
2021
2022: 8M (+14% vs 2021)
8M
+14%
2022
2023: 8M (0% vs 2022)
8M
0%
2023
2024: 8M (0% vs 2023)
8M
0%
2024
2025: 9M (+13% vs 2024)
9M
+13%
2025
EBITDA
EUR millions
0M
0M
-1M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: -1M
-1M
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
9 022
8 443
7 874
7 697
7 359
Staff expenses
−2 782
−3 103
−3 216
−2 500
−2 866
EBITDA
−199
−274
−665
73
129
Depreciation & amort.
−135
−136
−65
−74
−88
EBIT
−333
−410
−730
−0
41
Net financials
−25
−25
−1
−29
14
Profit before tax
−359
−435
−732
−29
54
Tax
−0
−7
−0
14
11
Net profit
−359
−428
−732
−43
43
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
2 986
2 938
2 829
3 052
3 300
Equity
524
883
1 112
2 019
2 162
Long-term debt
750
500
0
—
—
Short-term debt
1 712
1 555
1 717
1 033
1 138
Total debt
2 462
2 055
1 717
1 033
1 138
Financial ratios
5-year trend
EBITDA margin
−2,2 %
This company
15,8 %
Market median
This company
Market median
114% below market
2021
2025
Equity ratio
17,6 %
This company
38,2 %
Market median
This company
Market median
54% below market
2021
2025
Return on equity
−68,4 %
This company
18,4 %
Market median
This company
Market median
472% below market
2021
2025
Net profit margin
−4,0 %
This company
8,1 %
Market median
This company
Market median
149% below market
2021
2025
Asset turnover
3,02×
This company
1,12×
Market median
This company
Market median
170% above market
2021
2025
Debt / equity
4,69×
This company
0,62×
Market median
This company
Market median
656% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmadata Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
